Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180628040274N1Phase 3Completed
Phase 3 trial of acetaminophen and propofol in migraine (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Primary analgesic effect. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180628040274N1.